InvestorsHub Logo
Followers 130
Posts 14996
Boards Moderated 1
Alias Born 06/04/2018

Re: None

Tuesday, 12/03/2019 5:31:32 PM

Tuesday, December 03, 2019 5:31:32 PM

Post# of 894
News: $MACK Merrimack Pharmaceuticals Adopts Section 382 Net Operating Loss Rights Plan

Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) (the “ Company ” or “ Merrimack ”), announced today that its Board of Directors (the “ Board ”) has adopted a Section 382 net operating loss rights plan (the “ Plan ”) and declared a dividen...

Find out more MACK - Merrimack Pharmaceuticals Adopts Section 382 Net Operating Loss Rights Plan
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MACK News